Busulfan and subsequent malignancy: An evidence-based risk assessment.
Long-Boyle JR, Kohn DB, Shah AJ, Spencer SM, Sevilla J, Booth C, López Lorenzo JL, Nicoletti E, Shah A, Reatz M, Matos J, Schwartz JD.
Long-Boyle JR, et al. Among authors: spencer sm.
Pediatr Blood Cancer. 2024 Jan;71(1):e30738. doi: 10.1002/pbc.30738. Epub 2023 Oct 19.
Pediatr Blood Cancer. 2024.
PMID: 37856098